Latest News and Press Releases
Want to stay updated on the latest news?
-
BOSTON, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Zafgen, Inc. (Nasdaq:ZFGN), a clinical-stage biopharmaceutical company leveraging its proprietary knowledge of MetAP2 systems biology to develop novel...
-
Dallas, Aug. 06, 2019 (GLOBE NEWSWIRE) -- DALLAS, TEXAS …August 6, 2019 … CompX International Inc. (NYSE American: CIX) announced today sales of $33.7 million for the second quarter of 2019 compared...
-
TORONTO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- AGF Management Limited reported total fee-earning assets under management (AUM) of $37.8 billion as at July 31, 2019. AUM ($ billions)July 31, 2019June...
-
OKLAHOMA CITY, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Devon Energy Corp. (NYSE: DVN) today reported operational and financial results for the second quarter of 2019. The company’s earnings release,...
-
- Net Income up 24% to $13.9 Million, or $1.81 per Diluted Share - - Authorizes $50 Million Share Repurchase Program and Raises Quarterly Cash Dividend by 20% to $0.30 per Share - VANCOUVER, Wash.,...
-
CHICAGO, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Oil-Dri Corporation of America (NYSE: ODC) today announced that Daniel S. Jaffee, President & Chief Executive Officer, Susan M. Kreh, Chief Financial...
-
NEW YORK, Aug. 06, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Reckitt Benckiser Group plc ("Reckitt" or the "Company")...
-
Smithfield Foods Donates More Than 70,000 Pounds of Protein to Second Harvest Food Bank of Metrolina
CHARLOTTE, N.C., Aug. 06, 2019 (GLOBE NEWSWIRE) -- Smithfield Foods, Inc. donated more than 70,000 pounds of protein to Second Harvest Food Bank of Metrolina in Charlotte, North Carolina to support...
-
SAN CLEMENTE, Calif., Aug. 06, 2019 (GLOBE NEWSWIRE) -- CareTrust REIT, Inc. (Nasdaq:CTRE) today reported operating results for the quarter ended June 30, 2019, as well as other recent events. ...
-
Enrollment in Phase 2a expansion cohort testing ALRN-6924 in combination with Pfizer’s IBRANCE® (palbociclib) in MDM2-amplified cancers ongoing and ahead of schedule. Interim data on at least 15...